InvestSMART

Memphasys Limited (ASX: MEM) - Announcements

Current share price for MEM : $0.004 0.001 (20%)+

ASX company news and announcements for Memphasys Limited (MEM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Memphasys Limited (MEM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Memphasys Limited (MEM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Memphasys Limited (MEM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Notice of Annual General Meeting/Proxy Form 20 Oct 2023 3:17PM $0.010 $0.004 fallen by 60%
$12 In-Depth Investor Webinar Presentation 21 Sep 2023 9:15AM $0.013 $0.004 fallen by 69.23%
$12 Investor Presentation Sept 23 18 Sep 2023 2:07PM $0.014 $0.004 fallen by 71.43%
$12 Felix System records 10 new live births in India 15 Sep 2023 9:17AM $0.015 $0.004 fallen by 73.33%
$12 Notification of cessation of securities - MEM 15 Sep 2023 8:20AM $0.015 $0.004 fallen by 73.33%
$12 Preliminary Final Report 30 Aug 2023 4:43PM $0.014 $0.004 fallen by 71.43%
$12 Initial Felix System order placed by Vitrolife Japan 14 Aug 2023 8:34AM $0.014 $0.004 fallen by 71.43%
$12 Vitrolife sign Felix distribution agreement for Japanese mkt 7 Aug 2023 8:12AM $0.014 $0.004 fallen by 70.37%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2023 8:19AM $0.014 $0.004 fallen by 71.43%
$12 New Patents granted for Felix System 13 Jul 2023 8:16AM $0.016 $0.004 fallen by 75%
$12 Notification of cessation of securities - MEM 8 Jun 2023 4:38PM $0.015 $0.004 fallen by 73.33%
$12 Felix considered best method to treat cryopreserved semen 6 Jun 2023 8:23AM $0.016 $0.004 fallen by 75%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2023 10:02AM $0.020 $0.004 fallen by 80%
$12 Investor presentation April 2023 5 Apr 2023 9:33AM $0.017 $0.004 fallen by 76.47%
$12 Japan first commercial sale and first baby born using Felix 3 Apr 2023 8:21AM $0.016 $0.004 fallen by 75%
$12 Experienced fertility expert appointed Operations Director 30 Mar 2023 8:16AM $0.015 $0.004 fallen by 73.33%
$12 Highly-credentialled exec appointed as Director of BusDev 28 Feb 2023 8:19AM $0.016 $0.004 fallen by 75%
$12 Half Yearly Report and Accounts 24 Feb 2023 5:26PM $0.016 $0.004 fallen by 75%
$12 KOL testings demonstrate Felix System outperforms DGC 7 Feb 2023 8:56AM $0.015 $0.004 fallen by 73.33%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2023 8:51AM $0.015 $0.004 fallen by 73.33%
$12 Notification of cessation of securities - MEM 17 Jan 2023 8:22AM $0.014 $0.004 fallen by 71.43%
$12 Change of Director's Interest Notice correction 12 Jan 2023 5:23PM $0.015 $0.004 fallen by 73.33%
$12 Change of Director's Interest Notice correction 12 Jan 2023 10:06AM $0.015 $0.004 fallen by 73.33%
$12 Change of Director's Interest Notice - AC 3 Jan 2023 8:19AM $0.014 $0.004 fallen by 71.43%
$12 Change of Director's Interest Notice - AG 3 Jan 2023 8:18AM $0.014 $0.004 fallen by 71.43%

276 - 300 of 647 results

Page 12 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.